reyataz atazanavir (as sulfate) 300mg capsule bottle
bristol-myers squibb australia pty ltd - atazanavir sulfate, quantity: 341.69 mg (equivalent: atazanavir, qty 300 mg) - capsule, hard - excipient ingredients: crospovidone; magnesium stearate; lactose monohydrate; titanium dioxide; indigo carmine; iron oxide yellow; sorbitan monolaurate; iron oxide red; potable water; gelatin; iron oxide black; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; pharmaceutical glaze; dimeticone - reyataz is indicated for the treatment of hiv 1 infection, in combination with other antiretroviral agents. this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts from controlled studies (see 5.1 pharmacodynamic properties: clinical trials).
rifampicin 120mg/5ml oral suspension
special order - rifampicin - oral suspension - 24mg/1ml
rifampicin 150mg/5ml oral suspension
special order - rifampicin - oral suspension - 30mg/1ml
rifampicin 200mg/5ml oral suspension
special order - rifampicin - oral suspension - 40mg/1ml
rifampicin 30.5mg/5ml oral suspension
special order - rifampicin - oral suspension - 6.1mg/1ml
rifampicin 300mg/5ml oral suspension
special order - rifampicin - oral suspension - 60mg/1ml
rifampicin 480mg/5ml oral suspension
special order - rifampicin - oral suspension - 96mg/1ml
rifampicin 120mg/5ml oral solution
special order - rifampicin - oral solution - 24mg/1ml
rifampicin 150mg/5ml oral solution
special order - rifampicin - oral solution - 30mg/1ml
rifampicin 200mg/5ml oral solution
special order - rifampicin - oral solution - 40mg/1ml